The price/operating cash flow metric for Cryolife Inc is higher than 95.59% of stocks in our set with a positive cash flow.
Over the past twelve months, CRY has reported earnings growth of -99.49%, putting it ahead of only 19.32% of US stocks in our set.
Cryolife Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -9.73%, greater than the shareholder yield of merely 20.83% of stocks in our set.
Stocks that are quantitatively similar to CRY, based on their financial statements, market capitalization, and price volatility, are SILK, TELA, ESTA, VAPO, and STIM.
CryoLife Inc. engages in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac and vascular surgical procedures. The company was founded in 1984 and is based in Kennesaw, Georgia.
SMI has recently published a research report titled, “Global Specialty Surgical Wound Care Products Market Report 2020“. This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important research studies that
DUBLIN, Dec. 30, 2020 /PRNewswire/ -- The "Hemostasis and Tissue Sealing Agents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report has been added to ResearchAndMarkets.com's offering. This report on the global hemostasis and tissue sealing…
New Study On Heart Valve Market: According to the ‘Market Growth Insight’, the Heart Valve market is anticipated to be estimated at USD XX billion along with CAGR of XX% over the forecast period 2020 - 2026. The Heart Valve study